Do all obsessive-compulsive disorder subtypes respond to medication?

References

• Baer L. Factor analysis of symptom subtypes of obsessive compulsive disorder and their relation to personality and tic disorders. Journal of Clinical Psychiatry 1994; 55(Suppl.)18–3
   PubMed Web of Science ®Google Scholar
• Bloch MH, Landeros-Weisenberger A, Kelmendi B, Coric V, Bracken MB, Leckman JF. A systematic review: Antipsychotic augmentation with treatment refractory obsessive-compulsive disorder. Molecular Psychiatry 2006; 11: 622–32
   PubMed Web of Science ®Google Scholar
• Cullen B, Brown CH, Riddle MA, Grados M, Bienvenu OJ, Hoehn-Saric R, et al. Factor analysis of the Yale-Brown Obsessive Compulsive Scale in a family study of obsessive-compulsive disorder. Depression and Anxiety 2007; 24: 130–38
   PubMed Web of Science ®Google Scholar
• Dell'Osso B, Mundo E, Altamura AC. Quetiapine augmentation of selective serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: A six-month follow-up case series. CNS Spectrums 2006; 11: 879–83
   PubMed Web of Science ®Google Scholar
• Delorme R, Bille A, Betancur C, Mathieu F, Chabane N, Mouren-Simeoni MC, et al. Exploratory analysis of obsessive compulsive symptom dimensions in children and adolescents: A prospective follow-up study. BMC Psychiatry 2006; 6: 1–10
   PubMedGoogle Scholar
• Denys D, de Geus F, van Megen HJ, Westenberg HG. Use of factor analysis to detect potential phenotypes in obsessive-compulsive disorder. Psychiatry Research 2004; 128: 273–280
   PubMedGoogle Scholar
• Diniz JB, Rosario-Campos MC, Shavitt RG, Curi M, Hounie AG, Brotto SA, et al. Impact of age at onset and duration of illness on the expression of comorbidities in obsessive-compulsive disorder. Journal of Clinical Psychiatry 2004; 65: 22–27
   PubMed Web of Science ®Google Scholar
• do Rosario-Campos MC, Leckman JF, Curi M, Quatrano S, Katsovitch L, Miguel EC, et al. A family study of early-onset obsessive-compulsive disorder. American Journal of Medical Genetics B Neuropsychiatric Genetics, 136: 92–97, (7-5-2005)
   Google Scholar
• Fitzgerald KD, Stewart CM, Tawile V, Rosenberg DR. Risperidone augmentation of serotonin reuptake inhibitor treatment of pediatric obsessive compulsive disorder. Journal of Child Adolescent Psychopharmacology 1999; 9: 115–123
   PubMed Web of Science ®Google Scholar
• Flament MF, Rapoport JL, Berg CJ, Sceery W, Kilts C, Mellstrom B, et al. Clomipramine treatment of childhood obsessive-compulsive disorder. A double-blind controlled study. Archives of General Psychiatry 1985; 42: 977–983
   PubMed Web of Science ®Google Scholar
• Geller D, Biederman J, Jones J, Park K, Schwartz S, Shapiro S, et al. Is juvenile obsessive-compulsive disorder a developmental subtype of the disorder? A review of the pediatric literature. Journal of the American Academy of Child & Adolescent Psychiatry 1998; 37: 420–427
   PubMed Web of Science ®Google Scholar
• Geller DA, Biederman J, Faraone SV, Cradock K, Hagermoser L, Zaman N, et al. Attention-deficit/hyperactivity disorder in children and adolescents with obsessive-compulsive disorder: Fact or artifact?. Journal of the American Academy of Child & Adolescent Psychiatry 2002; 41: 52–58
   PubMed Web of Science ®Google Scholar
• Geller DA, Biederman J, Stewart SE, Mullin B, Farrell C, Wagner KD, et al. Impact of comorbidity on treatment response to paroxetine in pediatric obsessive-compulsive disorder: Is the use of exclusion criteria empirically supported in randomized clinical trials?. Journal of Child Adolescent Psychopharmacology 2003; 13(Suppl.1)S19–S29
   Google Scholar
• Geller DA, Wagner KD, Emslie G, Murphy T, Carpenter DJ, Wetherhold E, et al. Paroxetine treatment in children and adolescents with obsessive-compulsive disorder: A randomized, multicenter, double-blind, placebo-controlled trial. Journal of the American Academy of Child & Adolescent Psychiatry 2004; 43: 1387–1396
   PubMed Web of Science ®Google Scholar
• Josephson SC, Hollander E, Sumner J. Comprehensive treatment of three patients with comorbid OCPD and ADHD. CNS Spectrums 2007; 12: 338–342
   PubMedGoogle Scholar
• Kaplan A, Hollander E. Comorbidity in compulsive hoarding: A case report. CNS Spectrums 2004; 9: 71–73
   PubMed Web of Science ®Google Scholar
• Leckman JF, Grice DE, Barr LC, de Vries AL, Martin C, Cohen DJ, et al. Tic-related versus non-tic-related obsessive compulsive disorder. Anxiety 1994; 1: 208–215
   PubMedGoogle Scholar
• Leckman JF, Grice DE, Boardman J, Zhang H, Vitale A, Bondi C, et al. Symptoms of obsessive-compulsive disorder. American Journal of Psychiatry 1997; 154: 911–917
   PubMed Web of Science ®Google Scholar
• Leonard HL, Swedo SE, Lenane MC, Rettew DC, Cheslow DL, Hamburger SD, et al. A double-blind desipramine substitution during long-term clomipramine treatment in children and adolescents with obsessive-compulsive disorder. Archives of General Psychiatry 1991; 48: 922–927
   PubMed Web of Science ®Google Scholar
• Marazziti D, Pfanner C, Dell'Osso B, Ciapparelli A, Presta S, Corretti G, et al. Augmentation strategy with olanzapine in resistant obsessive compulsive disorder: An Italian long-term open-label study. Journal of Psychopharmacology 2005; 19: 392–394
   PubMed Web of Science ®Google Scholar
• March JS, Biederman J, Wolkow R, Safferman A, Mardekian J, Cook EH, et al. Sertraline in children and adolescents with obsessive-compulsive disorder: A multicenter randomized controlled trial. Journal of the American Medical Association 1998; 280: 1752–1756
   PubMed Web of Science ®Google Scholar
• March JS, Franklin ME, Leonard H, Garcia A, Moore P, Freeman J, et al. Tics moderate treatment outcome with sertraline but not cognitive-behavior therapy in pediatric obsessive-compulsive disorder. Biological Psychiatry 2007; 61: 344–347
   PubMed Web of Science ®Google Scholar
• Masi G, Millepiedi S, Mucci M, Bertini N, Milantoni L, Arcangeli F. A naturalistic study of referred children and adolescents with obsessive-compulsive disorder. Journal of the American Academy of Child & Adolescent Psychiatry 2005; 44: 673–681
   PubMed Web of Science ®Google Scholar
• Masi G, Millepiedi S, Mucci M, Bertini N, Pfanner C, Arcangeli F. Comorbidity of obsessive-compulsive disorder and attention-deficit/hyperactivity disorder in referred children and adolescents. Comprehensive Psychiatry 2006; 47: 42–47
   PubMed Web of Science ®Google Scholar
• Mataix-Cols D, Rauch SL, Manzo PA, Jenike MA, Baer L. Use of factor-analyzed symptom dimensions to predict outcome with serotonin reuptake inhibitors and placebo in the treatment of obsessive-compulsive disorder. American Journal of Psychiatry 1999; 156: 1409–1416
   PubMed Web of Science ®Google Scholar
• McDougle CJ, Epperson CN, Pelton GH, Wasylink S, Price LH. A double-blind, placebo-controlled study of risperidone addition in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder. Archives of General Psychiatry 2000; 57: 794–801
   PubMed Web of Science ®Google Scholar
• McDougle CJ, Goodman WK, Leckman JF, Lee NC, Heninger GR, Price LH. Haloperidol addition in fluvoxamine-refractory obsessive-compulsive disorder. A double-blind, placebo-controlled study in patients with and without tics. Archives of General Psychiatry 1994; 51: 302–308
   PubMed Web of Science ®Google Scholar
• Nestadt G, Addington A, Samuels J, Liang KY, Bienvenu OJ, Riddle M, et al. The identification of OCD-related subgroups based on comorbidity. Biological Psychiatry, 53: 914–920, (5-15-2003)
   PubMedGoogle Scholar
• Nestadt G, Samuels J, Riddle M, Bienvenu III OJ, Liang KY, LaBuda M, et al. A family study of obsessive-compulsive disorder. Archives of General Psychiatry 2000; 57: 358–363
   PubMed Web of Science ®Google Scholar
• Pauls DL, Alsobrook JP, Goodman W, Rasmussen S, Leckman JF. A family study of obsessive-compulsive disorder. American Journal of Psychiatry 1995; 152: 76–84
   PubMed Web of Science ®Google Scholar
• Pauls DL, Towbin KE, Leckman JF, Zahner GE, Cohen DJ. Gilles de la Tourette's syndrome and obsessive-compulsive disorder. Evidence supporting a genetic relationship. Archives of General Psychiatry 1986; 43: 1180–1182
   PubMed Web of Science ®Google Scholar
• Pinto A, Eisen JL, Mancebo MC, Greenberg BD, Stout RL, Rasmussen SA. Taboo thoughts and doubt/checking: A refinement of the factor structure for obsessive-compulsive disorder symptoms. Psychiatry Research 2007; 151: 255–258
   PubMedGoogle Scholar
• Riddle MA, Reeve EA, Yaryura-Tobias JA, Yang HM, Claghorn JL, Gaffney G, et al. Fluvoxamine for children and adolescents with obsessive-compulsive disorder: A randomized, controlled, multicenter trial. Journal of the American Academy of Child & Adolescent Psychiatry 2001; 40: 222–229
   PubMed Web of Science ®Google Scholar
• Riddle MA, Scahill L, King RA, Hardin MT, Anderson GM, Ort SI, et al. Double-blind, crossover trial of fluoxetine and placebo in children and adolescents with obsessive-compulsive disorder. Journal of the American Academy of Child & Adolescent Psychiatry 1992; 31: 1062–1069
   PubMed Web of Science ®Google Scholar
• Rosario-Campos MC, Leckman JF, Mercadante MT, Shavitt RG, Prado HS, Sada P, et al. Adults with early-onset obsessive-compulsive disorder. American Journal of Psychiatry 2001; 158: 1899–1903
   PubMed Web of Science ®Google Scholar
• Rosenberg DR, Stewart CM, Fitzgerald KD, Tawile V, Carroll E. Paroxetine open-label treatment of pediatric outpatients with obsessive-compulsive disorder. Journal of the American Academy of Child & Adolescent Psychiatry 1999; 38: 1180–1185
   PubMed Web of Science ®Google Scholar
• Samuels J, Bienvenu III OJ, Riddle MA, Cullen BA, Grados MA, Liang KY, et al. Hoarding in obsessive compulsive disorder: Results from a case-control study. Behavior Research and Therapy 2002; 40: 517–528
   PubMed Web of Science ®Google Scholar
• Samuels JF, Bienvenu III OJ, Pinto A, Fyer AJ, McCracken JT, Rauch SL, et al. Hoarding in obsessive-compulsive disorder: Results from the OCD Collaborative Genetics Study. Behavior Research and Therapy 2007; 45: 673–686
   PubMed Web of Science ®Google Scholar
• Saxena S, Brody AL, Maidment KM, Smith EC, Zohrabi N, Katz E, et al. Cerebral glucose metabolism in obsessive-compulsive hoarding. American Journal of Psychiatry 2004; 161: 1038–1048
   PubMed Web of Science ®Google Scholar
• Saxena S, Maidment KM, Vapnik T, Golden G, Rishwain T, Rosen RM, et al. Obsessive-compulsive hoarding: Symptom severity and response to multimodal treatment. Journal of Clinical Psychiatry 2002; 63: 21–27
   PubMed Web of Science ®Google Scholar
• Shapira NA, Ward HE, Mandoki M, Murphy TK, Yang MC, Blier P, et al. A double-blind, placebo-controlled trial of olanzapine addition in fluoxetine-refractory obsessive-compulsive disorder. Biological Psychiatry, 55: 553–555, (3-1-2004)
   PubMedGoogle Scholar
• Wever C, Rey JM. Juvenile obsessive-compulsive disorder. Australia and New Zealand Journal of Psychiatry 1997; 31: 105–113
   PubMed Web of Science ®Google Scholar